You are on page 1of 1

Integrative healthcare solution for schizophrenic and depressive disorders

For the first time scientific research has shown that levels of IL-6, IL-18, TNF, and sIL-2R are elevated in Major
depression Disorder (MDD) and schizophrenic patients. Il-18 is important in regulating immune function.
Furthermore, patients in the schizophrenia group showed higher levels of the inflammatory markers than MDD
and control groups.
The study authors Al-Hakeim et al concluded that the immunological response in the MDD and schizophrenic
patients groups was significantly stimulated and that these disorders may be considered an inflammatory
disorder because of elevated levels of proinflammatory cytokines in spite of lacking an overt inflammation.
Furthermore they suggested and Integrative healthcare solution of using anti-inflammatory drugs as adjuvant
therapy in schizophrenic and depressive disorders.

You might also like